165 related articles for article (PubMed ID: 8008331)
1. Relation of amniotic fluid C-peptide levels to neonatal body composition.
Krew MA; Kehl RJ; Thomas A; Catalano PM
Obstet Gynecol; 1994 Jul; 84(1):96-100. PubMed ID: 8008331
[TBL] [Abstract][Full Text] [Related]
2. Effect of maternal metabolism on fetal growth and body composition.
Catalano PM; Thomas AJ; Huston LP; Fung CM
Diabetes Care; 1998 Aug; 21 Suppl 2():B85-90. PubMed ID: 9704233
[TBL] [Abstract][Full Text] [Related]
3. [Correlation between amniotic fluid glucose concentration and amniotic fluid volume and neonatal birth weight in pregnancy complicated by gestational diabetes mellitus].
Xu ZM; Wu LF
Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):724-8. PubMed ID: 17327026
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of fetal growth by estimation of neonatal body composition.
Catalano PM; Tyzbir ED; Allen SR; McBean JH; McAuliffe TL
Obstet Gynecol; 1992 Jan; 79(1):46-50. PubMed ID: 1727584
[TBL] [Abstract][Full Text] [Related]
5. [Amniotic fluid insulin levels versus mean maternal blood glucose levels in gestational diabetes mellitus: an analysis of the neonatal outcome].
Holzapfel-Bauer M; Magnet E; Eder M; Haas J; Desoye G; Lang U
Gynakol Geburtshilfliche Rundsch; 2009; 49(4):249-53. PubMed ID: 20530937
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factors I and II peptide and messenger RNA levels in macrosomic infants of diabetic pregnancies.
Roth S; Abernathy MP; Lee WH; Pratt L; Denne S; Golichowski A; Pescovitz OH
J Soc Gynecol Investig; 1996; 3(2):78-84. PubMed ID: 8796812
[TBL] [Abstract][Full Text] [Related]
7. [Association between amniotic fluid insulin in the second trimester, maternal glucose tolerance and fetal malformations].
Bühling KJ; Mönnich J; Henrich W; Brauer M; Heinze T; Siebert G; Dudenhausen JW
Z Geburtshilfe Neonatol; 2004 Dec; 208(6):226-31. PubMed ID: 15647986
[TBL] [Abstract][Full Text] [Related]
8. Amniotic fluid C-peptide and cortisol in normal and diabetic pregnancies and pregnancies accompanied by fetal growth retardation.
Pschera H; Persson B; Lunell NO
Am J Perinatol; 1986 Jan; 3(1):16-21. PubMed ID: 3942608
[TBL] [Abstract][Full Text] [Related]
9. The relationship among intrauterine growth, insulinlike growth factor I (IGF-I), IGF-binding protein-3, and bone mineral status in newborn infants.
Akcakus M; Koklu E; Kurtoglu S; Kula M; Koklu SS
Am J Perinatol; 2006 Nov; 23(8):473-80. PubMed ID: 17094045
[TBL] [Abstract][Full Text] [Related]
10. [Correlation of maternal serum and amniotic fluid leptin and insulin levels with neonatal birth weight].
Perlitz Y; Gtezer-Soltzman S; Peleg A; Lang N; Almog B; Ben-Ami M
Harefuah; 2009 Jul; 148(7):420-3, 477. PubMed ID: 19848325
[TBL] [Abstract][Full Text] [Related]
11. Effect of fetal hyperinsulinism on oral glucose tolerance test results in patients with gestational diabetes mellitus.
Weiss PA; Scholz HS; Haas J; Tamussino KF
Am J Obstet Gynecol; 2001 Feb; 184(3):470-5. PubMed ID: 11228505
[TBL] [Abstract][Full Text] [Related]
12. Amniotic fluid content of glucose, C-peptide and insulin in normal and diabetic pregnancies.
Greco AV; Rebuzzi AG; Serri F; Altomonte L; Ghirlanda G; Manna R; Moneta E
Horm Metab Res; 1984 Dec; 16 Suppl 1():180-2. PubMed ID: 6398260
[TBL] [Abstract][Full Text] [Related]
13. Maternal insulin sensitivity and cord blood peptides: relationships to neonatal size at birth.
Bernstein IM; Goran MI; Copeland KC
Obstet Gynecol; 1997 Nov; 90(5):780-3. PubMed ID: 9351764
[TBL] [Abstract][Full Text] [Related]
14. Increased neonatal fat mass, not lean body mass, is associated with maternal obesity.
Sewell MF; Huston-Presley L; Super DM; Catalano P
Am J Obstet Gynecol; 2006 Oct; 195(4):1100-3. PubMed ID: 16875645
[TBL] [Abstract][Full Text] [Related]
15. Fetal beta cell function in diabetic pregnancy. Amniotic fluid concentrations of proinsulin, insulin, and C-peptide during the last trimester of pregnancy.
Persson B; Heding LG; Lunell NO; Pschera H; Stangenberg M; Wager J
Am J Obstet Gynecol; 1982 Oct; 144(4):455-9. PubMed ID: 6751089
[TBL] [Abstract][Full Text] [Related]
16. Midtrimester amniotic fluid leptin and insulin levels and subsequent gestational diabetes.
D'Anna R; Baviera G; Cannata ML; De Vivo A; Di Benedetto A; Corrado F
Gynecol Obstet Invest; 2007; 64(2):65-8. PubMed ID: 17264515
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid composition of amniotic fluid lecithin and its relationship to amniotic fluid C-peptide in diabetic pregnancy.
Pschera H; Persson B; Lunell NO
Horm Metab Res; 1984 Dec; 16 Suppl 1():186-9. PubMed ID: 6532935
[TBL] [Abstract][Full Text] [Related]
18. Analysis of carbohydrate-intolerant profiles of mothers with normal glucose tolerance tests and their large for gestational age neonates.
Fukui R; Matsuzaki N; Fujita T; Kidoguchi K; Suehara N; Aono T
Obstet Gynecol; 1995 Feb; 85(2):242-9. PubMed ID: 7824239
[TBL] [Abstract][Full Text] [Related]
19. The association of birthweight with maternal and cord serum and amniotic fluid growth hormone and insulin levels, and with neonatal and maternal factors in pregnant women who delivered at term.
Osmanağaoğlu MA; Osmanağaoğlu S; Bozkaya H
J Perinat Med; 2005; 33(2):149-55. PubMed ID: 15843266
[TBL] [Abstract][Full Text] [Related]
20. [Study on the relationships between leptin levels and weights of mothers and infants and the relationships of cord serum leptin to C-peptide, insulin and insulin like growth factor-II].
Lu Y; Hao X; Weng X
Zhonghua Fu Chan Ke Za Zhi; 2000 Oct; 35(10):603-5. PubMed ID: 11372411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
